Can a new tracer light up tumors better than standard PET scans?
NCT ID NCT07741006
First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time
Summary
This trial is testing an experimental imaging agent called [68Ga]Ga-ELI411, which is designed to bind to a protein (FAP) found in many solid tumors. The study will involve 18 adults with confirmed solid tumors who are already scheduled for a standard FDG-PET scan. Participants will receive a single injection of the new tracer and undergo additional PET imaging to evaluate its safety, how it spreads through the body, and whether it can detect tumors as well as or better than the standard scan.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- [68Ga]Ga-ELI411, an experimental PET imaging tracer
- What this could lead to
- If successful, this could lead to a more precise PET imaging method for detecting and evaluating solid tumors, potentially improving cancer diagnosis and treatment planning.
- What could go wrong
- This is an early-phase, small study (18 participants) focused on safety and imaging performance, not treatment. The tracer may not prove more effective than existing FDG-PET, and results may not generalize beyond the specific patient group.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Union Hospital, Huazhong University of Science and Technology
Wuhan, Hubei, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Ear acupressure: a new weapon against chemotherapy side effects?
- Can a Custom-Made immune cell vaccine turn the tide against solid tumors?
- Personalized weight loss coaching could help cancer survivors shed pounds
- Healthy volunteers needed to test new version of cancer drug
- New PET tracer aims to light up tumors, but trial stalls
- New injection aims to fight Cancer-Related wasting